Does UBLITUXIMAB Cause Multiple sclerosis relapse? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Multiple sclerosis relapse have been filed in association with UBLITUXIMAB (BRIUMVI). This represents 3.0% of all adverse event reports for UBLITUXIMAB.
48
Reports of Multiple sclerosis relapse with UBLITUXIMAB
3.0%
of all UBLITUXIMAB reports
1
Deaths
18
Hospitalizations
How Dangerous Is Multiple sclerosis relapse From UBLITUXIMAB?
Of the 48 reports, 1 (2.1%) resulted in death, 18 (37.5%) required hospitalization.
Is Multiple sclerosis relapse Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UBLITUXIMAB. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does UBLITUXIMAB Cause?
Infusion related reaction (538)
Fatigue (110)
Headache (55)
Inappropriate schedule of product administration (53)
Malaise (49)
Asthenia (45)
Pain (45)
Illness (43)
Urinary tract infection (42)
Covid-19 (39)
What Other Drugs Cause Multiple sclerosis relapse?
DIMETHYL (6,852)
FINGOLIMOD (6,728)
NATALIZUMAB (6,478)
INTERFERON BETA-1A (5,931)
TERIFLUNOMIDE (4,745)
GLATIRAMER (3,695)
DALFAMPRIDINE (3,322)
OCRELIZUMAB (2,326)
OFATUMUMAB (1,525)
INTERFERON BETA-1B (1,229)
Which UBLITUXIMAB Alternatives Have Lower Multiple sclerosis relapse Risk?
UBLITUXIMAB vs UBLITUXIMAB-XIIY
UBLITUXIMAB vs UBROGEPANT
UBLITUXIMAB vs ULIPRISTAL
UBLITUXIMAB vs UMBRALISIB
UBLITUXIMAB vs UMECLIDINIUM